← Leaderboards
Nigel D Priestley
University Of Montana
$4,246,110
Attributed
$4,246,110
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $750.4K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$4,246,110 · 7
By mechanism
R42$1,496,891 · 1
R01$1,262,953 · 1
R43$513,390 · 2
R15$410,350 · 1
R41$295,729 · 1
R29$266,797 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “P Glycoprotein”
- Rodger Paul McEver · University Of Oklahoma Hlth Sciences Ctr$15,617,119
- Stuart A Kornfeld · Washington University$12,060,785
- Thomas Paul Davis · University Of Arizona$10,319,251
- David W Haas · Vanderbilt University Medical Center$8,543,453
- Robert H Mach · Wake Forest University$8,516,176
- Beth A McCormick · Univ Of Massachusetts Med Sch Worcester$7,449,258
Research focus
P GlycoproteinDrug Design /Synthesis /ProductionStructureBaseStaphylococcus AureusResistanceCommunicable DiseasesPathogenAntineoplastic AntibioticsMultidrug ResistanceMicroorganism MetabolismEvaluationAntibioticsPharmaceutical PreparationsLeadStreptomycesAnti-Bacterial AgentsAntibiotic ResistanceMouse ModelMutantEventInfectionDesignAnalog
Grant awards (13)
Novel antibacterial agents derived from natural products$750,375
R42 · FY2020 · AI · contact PI
Novel antibacterial agents derived from natural products$746,516
R42 · FY2019 · AI · contact PI
Novel antibacterial agents derived from natural products$295,729
R41 · FY2016 · AI · contact PI
Non-nucleoside inhibitors of DNA methyl transferase I$410,350
R15 · FY2013 · CA · contact PI
Development of stable isosteres of dihydrofolate reductase inhibitors as antibact$287,766
R43 · FY2013 · AI · contact PI
Isoindolinones as Antimicrobial Agents$225,624
R43 · FY2008 · AI · contact PI
BIO-ENGINEERING OF COMPOUNDS ACTIVE AGAINST MDR CANCER$314,661
R01 · FY2006 · CA · contact PI
BIO-ENGINEERING OF COMPOUNDS ACTIVE AGAINST MDR CANCER$319,372
R01 · FY2005 · CA
BIO-ENGINEERING OF COMPOUNDS ACTIVE AGAINST MDR CANCER$316,050
R01 · FY2004 · CA
BIO-ENGINEERING OF COMPOUNDS ACTIVE AGAINST MDR CANCER$312,870
R01 · FY2003 · CA
BIO-ENGINEERING OF COMPOUNDS ACTIVE AGAINST MDR CANCER$95,437
R29 · FY2002 · CA
BIO-ENGINEERING OF COMPOUNDS ACTIVE AGAINST MDR CANCER$92,298
R29 · FY2001 · CA
BIO-ENGINEERING OF COMPOUNDS ACTIVE AGAINST MDR CANCER$79,062
R29 · FY2000 · CA